CHARLESTOWN PHARMACY LIMITED
- · Thesis: well-run, low negotiation leverage
No material changes in the last 30 days.
No snapshot from 90 days ago — start tracking from today.
No snapshot from 180 days ago — start tracking from today.
Opportunity 81/100 (exceptional), bankability 75/100. Strong seller-intent signal (70/100, director aged 64). Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Average employees | 5 | 500 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
- • 1 accounts
- • 1 confirmation-statement
Corporate timeline (25 events)Click to expand
- 2026-03-23📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-03-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-12-19📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2024-03-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-08-14📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-03-16📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-02-15📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-02-15📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2022-03-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-03-19📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-03-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-04-01📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-04-05📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-03-28📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-03-21📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2011-01-06🏢Company incorporatedAs CHARLESTOWN PHARMACY LIMITED
- 2011-01-06➕CHAN, Yuk, Dr appointedsecretary
- 2011-01-06➕CHAN, Yuk, Doctor appointeddirector
- 2011-01-06➕FLEMING, Charles appointeddirector
- 2011-01-06➕TRAINER, Peter appointedsecretary
- 2011-01-06➖TRAINER, Peter resignedsecretary
- 2011-01-06➕MCINTOSH, Susan appointeddirector
- 2011-01-06➖MCINTOSH, Susan resigneddirector
- 2011-01-06➕TRAINER, Peter appointeddirector
- 2011-01-06➖TRAINER, Peter resigneddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Long-tenure founder: Senior director has been in place 15 years — deep operational knowledge concentrated in one person.
- +Senior director age: Director aged approximately 64 — approaching natural succession window.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- secondary12+ year tenure: Director in role 15 years.
- secondaryStable-but-static management: Company is 15 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Charles Fleming Individual · British · DOB 10/1962 · age 64 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 30/06/2016 |
Dr. Yuk Chan Individual · Scottish · DOB 01/1966 · age 60 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 30/06/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · KY postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ABBOTSFORD CARE (GLENROTHES) LIMITED→ SC370558 · est 2009 | £11.35M £8.17M–£14.53M | £18.42M | — | 60000 | 16y | 81 | 70y |
| THE DAISYCHAIN NURSERY KIRKCALDY LTD.→ SC263422 · est 2004 | — | — | — | 5200 | 22y | 83 | 78y |
| PITLAIR LIMITED→ SC164594 · est 1996 | — | — | — | 5800 | 30y | 82 | 80y |
| R MITEVA & ASSOCIATES LIMITED→ SC379836 · est 2010 | — | — | £574.1k | — | 15y | 82 | 63y |
| RIVENDELL CARE SERVICES LIMITED→ SC329079 · est 2007 | — | — | £273.5k | — | 18y | 82 | 86y |
| FIFE INTENSIVE REHABILITATION AND SUBSTANCE USE TEAM (FIRST) LIMITED→ SC298843 · est 2006 · no financials extracted | — | — | — | — | 20y | 81 | 80y |
| FIFE SHOPPING & SUPPORT SERVICES LTD→ SC384248 · est 2010 · no financials extracted | — | — | — | — | 15y | 81 | 69y |
| GIBSON TRAINING AND CARE LIMITED→ SC331626 · est 2007 | — | — | £81 | — | 18y | 81 | 82y |
| QA CONNECTIONS LTD→ SC379457 · est 2010 · no financials extracted | — | — | — | — | 15y | 81 | 64y |
| THE FIFE HERBAL DISPENSARY LIMITED→ SC284939 · est 2005 | — | — | — | — | 21y | 81 | 80y |
| BANDRUM NURSING HOME LIMITED→ SC099467 · est 1986 · no financials extracted | — | — | — | — | 39y | 80 | 88y |
| COLORECTAL LTD.→ SC261429 · est 2004 | — | — | — | 100 | 22y | 80 | 64y |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (3 active · 3 resigned)
Click a director name to see their full track record across all companies.